Rising Pharma Holdings recalls
1 recall filed under Rising Pharma Holdings. The most recent was published July 18, 2026.
-
Class II · 3 months ago
Rising Pharma Holdings Cetirizine Hydrochloride Tablets USP 5 mg recall: Potential cross contamination with Ranitidine
Potential cross contamination with Ranitidine
About this page
Rising Pharma Holdings appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.